Source: ClinicaSpace

Genisphere: Genisphere Raises $7M to Advance 3DNA Drug Delivery System

Genisphere completed the raise to support accelerating interest in advancing its 3DNA scaffold into the clinic and enabling follow-on studies and programs currently underway with biotech and pharma partners.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
100-250
Thomas H. Bliss's photo - CEO of Genisphere

CEO

Thomas H. Bliss

CEO Approval Rating

75/100

Read more